These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8583252)

  • 1. Improved synthesis of zebularine [1-(beta-D-ribofuranosyl)-dihydropyrimidin-2-one] nucleotides as inhibitors of human deoxycytidylate deaminase.
    Barchi JJ; Cooney DA; Hao Z; Weinberg ZH; Taft C; Marquez VE; Ford H
    J Enzyme Inhib; 1995; 9(2):147-62. PubMed ID: 8583252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
    Heinemann V; Plunkett W
    Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase.
    Kim CH; Marquez VE; Mao DT; Haines DR; McCormack JJ
    J Med Chem; 1986 Aug; 29(8):1374-80. PubMed ID: 3735306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine).
    Jeong LS; Buenger G; McCormack JJ; Cooney DA; Hao Z; Marquez VE
    J Med Chem; 1998 Jul; 41(14):2572-8. PubMed ID: 9651161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of deoxycytidylate deaminase in intact human leukemia cells. Action of 2',2'-difluorodeoxycytidine.
    Xu YZ; Plunkett W
    Biochem Pharmacol; 1992 Nov; 44(9):1819-27. PubMed ID: 1449536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epimer interconversion, isomerization, and hydrolysis of tetrahydrouridine: implications for cytidine deaminase inhibition.
    Xiang TX; Niemi R; Bummer P; Anderson BD
    J Pharm Sci; 2003 Oct; 92(10):2027-39. PubMed ID: 14502542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
    Grant S; Bhalla K; McCrady C
    Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effect of phosphorylated metabolites of anti-human immunodeficiency virus and anti-hepatitis B virus pyrimidine analogs on the behavior of human deoxycytidylate deaminase.
    Liou JY; Krishnan P; Hsieh CC; Dutschman GE; Cheng YC
    Mol Pharmacol; 2003 Jan; 63(1):105-10. PubMed ID: 12488542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic behaviour and allosteric regulation of human deoxycytidylate deaminase derived from leukemic cells.
    Ellims PH; Kao AY; Chabner BA
    Mol Cell Biochem; 1983; 57(2):185-90. PubMed ID: 6581381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of an affinity-column-purified human deoxycytidylate deaminase.
    Maley GF; Lobo AP; Maley F
    Biochim Biophys Acta; 1993 Mar; 1162(1-2):161-70. PubMed ID: 8448179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
    Momparler RL; Rossi M; Bouchard J; Vaccaro C; Momparler LF; Bartolucci S
    Mol Pharmacol; 1984 May; 25(3):436-40. PubMed ID: 6203026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 1-beta-D-ribofuranosyl-1,2-dihydropyrimidin-2-one derivatives and their biological activities.
    Maeda M; Kaneko C; Uchida NA; Sasaki T
    Nucleic Acids Symp Ser; 1985; (16):77-80. PubMed ID: 4088888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The first crystal structure of a dTTP-bound deoxycytidylate deaminase validates and details the allosteric-inhibitor binding site.
    Marx A; Alian A
    J Biol Chem; 2015 Jan; 290(1):682-90. PubMed ID: 25404739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxycytidylate deaminase from Bacillus subtilis. Purification, characterization, and physiological function.
    Møllgaard H; Neuhard J
    J Biol Chem; 1978 May; 253(10):3536-42. PubMed ID: 418064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional structure of the R115E mutant of T4-bacteriophage 2'-deoxycytidylate deaminase.
    Almog R; Maley F; Maley GF; Maccoll R; Van Roey P
    Biochemistry; 2004 Nov; 43(43):13715-23. PubMed ID: 15504034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deoxycytidine transport and pyrimidine deoxynucleotide metabolism in phytohaemagglutinin-stimulated pig lymphocytes.
    Barlow SD
    Biochem J; 1976 Feb; 154(2):395-403. PubMed ID: 938456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2'-deoxycytidine by human cytidine deaminase.
    Laliberté J; Marquez VE; Momparler RL
    Cancer Chemother Pharmacol; 1992; 30(1):7-11. PubMed ID: 1375134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxycytidylate deaminase. Purification and some properties of the enzyme isolated from human spleen.
    Ellims PH; Kao AY; Chabner BA
    J Biol Chem; 1981 Jun; 256(12):6335-40. PubMed ID: 7240207
    [No Abstract]   [Full Text] [Related]  

  • 19. Deoxycytidylate deaminase activity in non-stimulated and phytohemagglutinin-stimulated human lymphocytes, and in leukemic cells.
    Tyrsted G; Chao PC; Munch-Petersen B
    Mol Cell Biochem; 1987 Jul; 76(1):27-34. PubMed ID: 3627112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of Streptococcus mutans 2'-deoxycytidylate deaminase and its complex with substrate analog and allosteric regulator dCTP x Mg2+.
    Hou HF; Liang YH; Li LF; Su XD; Dong YH
    J Mol Biol; 2008 Mar; 377(1):220-31. PubMed ID: 18255096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.